Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross‐sectional study

Abstract

Severe weight increment is frequent on IFX treatment, mainly in men, and patients with severe psoriasis. Dietary follow-up or simultaneous use of methotrexate could limit this weight increment.